Press Releases

Press Releases

July 29, 2020

Keystone Heart, A Venus Medtech Company, Announces First Commercial Case Performed Worldwide with the TriGUARD 3™ Cerebral Embolic Protection Device

TAMPA, Fla., July 29, 2020 /PRNewswire/ -- Keystone Heart, LTD., a medical device innovator driven to redefine the standard of structural heart care,...
Read More
June 16, 2020

Keystone Heart, A Venus Medtech Company, Acquires 510 Kardiac Devices, Inc.

TAMPA, Fla., June 16, 2020 /PRNewswire/ -- Keystone Heart, LTD., a medical device innovator driven to redefine the standard of structural heart care,...
Read More
March 10, 2020

TriGUARD 3™ Cerebral Embolic Protection Device Receives CE Mark for Use in Transcatheter Heart Procedures

TAMPA, Fla., March 10, 2020 /PRNewswire/ -- Keystone Heart Ltd., a Venus Medtech Company, today announced European CE Mark for the TriGUARD 3™...
Read More
December 26, 2018

Venus Medtech Completes Merger with Keystone Heart, Ltd.

HANGZHOU, China and CAESAREA, Israel and TAMPA, Fla., Dec. 26, 2018 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc., the preeminent Chinese transcatheter heart valve company, today announced it has closed...
Read More
September 25, 2018

Venus Medtech Announces Agreement to Acquire Keystone Heart, LTD

HANGZHOU, China and CAESAREA, Israel and TAMPA, Florida, Sept. 25, 2018 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc., the preeminent Chinese transcatheter heart valve company, today announced it has...
Read More
Triguard

The Only CE Marked Cerebral Embolic Protection Device Designed to Cover all Three Major Aortic Vessels.

Cerebral Embolic Protection Device

Stay Updated on the latest Blogs from Keystone Heart.

Skip to content